Secondary Prevention of Esophageal Variceal Bleeding Using Transjugular Intrahepatic Portosystemic Shunt Compared to Endoscopic Band Ligation plus Beta-Blocker
), Saskia Aziza Nursyirwan(2),
(1) Faculty of Medicine, Universitas Indonesia, Jakarta
(2) Division of Gastroenterology, Pancreatobiliary, and Digestive Endoscopy, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Dr. Cipto Mangunkusumo General National Hospital, Jakarta
Corresponding Author
Abstract
Aim: This study aims to compare the effectiveness of transjugular intrahepatic portosystemic shunt (TIPS) against combination therapy in the secondary prevention of esophageal variceal bleeding.
Method: Literature search was conducted using 4 databases (PubMed, Cochrane, Ovid MEDLINE, and Ovid Embase) and individual hand searching. The selected studies were then critically appraised for their validity, importance, and applicability.
Results: A total of 136 results were retrieved, and 2 systematic reviews and meta-analysis of randomized controlled trials (RCTs) were selected. Both studies showed that TIPS significantly decreased incidence of esophageal variceal rebleeding but had no significant effect on reducing overall mortality when compared to combination therapy. Study by Lin et al found that TIPS was significantly better than combination therapy for reducing mortality from variceal rebleeding, but study by Jing et al found no significant difference.
Conclusion: TIPS is superior to combination therapy in reducing the incidence of esophageal variceal rebleeding. Nevertheless, its effectiveness in reducing mortality needs further investigation. Future research should look into its complications and cost-effectiveness in developing countries like Indonesia.
Keywords
References
Meseeha M, Attia M. Esophageal varices. In: StatPearls [serial
online]. Treasure Island (FL): StatPearls Publishing; 2022
[cited 2022 Jul 14]. Available from: http://www.ncbi.nlm.nih.
gov/books/NBK448078/.
Iwakiri Y, Trebicka J. Portal hypertension in cirrhosis:
pathophysiological mechanisms and therapy. JHEP Reports.
;3(4):100316.
Jakab SS, Garcia-Tsao G. Evaluation and management of
esophageal and gastric varices in patients with cirrhosis. Clin
Liver Dis 2020;24:335–50.
Pallio S, Melita G, Shahini E, Vitello A, Sinagra E, Lattanzi B,
et al. Diagnosis and management of esophagogastric varices.
Diagnostics. 2023;13(6):1031.
Pfisterer N, Unger LW, Reiberger T. Clinical algorithms for
the prevention of variceal bleeding and rebleeding in patients
with liver cirrhosis. World J Hepatol. 2021;13(7):731–46.
Miao Z, Lu J, Yan J, Lu L, Ye B, Gu M. Comparison of
therapies for secondary prophylaxis of esophageal variceal
bleeding in cirrhosis: a network meta-analysis of randomized
controlled trials. Clin Ther 2020;42:1246-75.
García-Pagán JC, Caca K, Bureau C, Laleman W, Appenrodt
B, Luca A, et al. Early use of TIPS in patients with cirrhosis
and variceal bleeding. N Engl J Med 2010;362:2370–9.
Shi KQ, Liu WY, Pan ZZ, Ling XF, Chen SL, Chen YP, et
al. Secondary prophylaxis of variceal bleeding for cirrhotic
patients: a multiple-treatments meta-analysis. Eur J Clin Invest
;43:844–54.
Oxford Centre for Evidence-Based Medicine. Critical
Appraisal Tool [serial online] 2022 [cited 2022 Jul 15].
Available from: https://www.cebm.ox.ac.uk/resources/ebmtools/
critical-appraisal-tools.
Lin LL, Du SM, Fu Y, Gu HY, Wang L, Jian ZY, et al.
Combination therapy versus pharmacotherapy, endoscopic
variceal ligation, or the transjugular intrahepatic portosystemic
shunt alone in the secondary prevention of esophageal variceal
bleeding: a meta-analysis of randomized controlled trials.
Oncotarget 2017;8:57399–408.
Jing L, Zhang Q, Chang Z, Liu H, Shi X, Li X, et al.
Nonsurgical secondary prophylaxis of esophageal variceal
bleeding in cirrhotic patients: a systematic review and network
meta-analysis. J Clin Gastroenterol 2021;55:159–68.
Bandali MF, Mirakhur A. Portosystemic collateral pathways
and interventions in portal hypertension. Int J Gastrointest
Interv. 2018;7(1):21–8.
Loffroy R, Favelier S, Pottecher P, Estivalet L, Genson PY,
Gehin S, et al. Transjugular intrahepatic portosystemic shunt for
acute variceal gastrointestinal bleeding: indications, techniques
and outcomes. Diagn Interv Imaging 2015;96:745–55.
Rodrigues SG, Mendoza YP, Bosch J. Beta-blockers in
cirrhosis: Evidence-based indications and limitations. JHEP
Rep. 2019;2(1):100063.
Razafindrazoto CI, Randriamifidy NH, Rakotomalala JA,
Rakotondrasoa SR, Ralaizanaka BM, Rakotoniaina H, et
al. Endoscopic variceal ligation in primary and secondary
prevention of variceal bleeding: a retrospective study in
Digestive Endoscopy Unit, University Hospital Joseph Raseta
Befelatanana, Antananarivo, Madagascar. Egypt Liver J.
;13(1):60.
Nett A, Binmoeller KF. Endoscopic management of portal
hypertension-related bleeding. Gastrointest Endosc Clin N
Am. 2019;29(2):321–37.
Schindler P, Heinzow H, Trebicka J, Wildgruber M. Shuntinduced
hepatic encephalopathy in TIPS: current approaches
and clinical challenges. J Clin Med 2020;9:E3784.
Rajesh S, George T, Philips CA, Ahamed R, Kumbar S, Mohan
N, et al. Transjugular intrahepatic portosystemic shunt in
cirrhosis: An exhaustive critical update. World J Gastroenterol
;26:5561–96.
Weissenborn K. Hepatic encephalopathy: definition, clinical
grading and diagnostic principles. Drugs 2019;79:5–9.
Seifert LL, Schindler P, Schoster M, Weller JF, Wilms C,
Schmidt HH, et al. Recurrence of hepatic encephalopathy after
TIPS: effective prophylaxis with combination of lactulose and
rifaximin. J Clin Med 2021;10:4763.
Bucsics T, Schoder M, Diermayr M, Feldner-Busztin
M, Goeschl N, Bauer D, et al. Transjugular intrahepatic
portosystemic shunts (TIPS) for the prevention of variceal
re-bleeding – a two decades experience. Strnad P, editor. PLoS
ONE. 2018;13(1):e0189414.
Shen NT, Namn Y, Schneider Y, Jesudian A, Fortune B,
Rosenblatt R, et al. Cost-effectiveness of transjugular
intrahepatic portosystemic shunt (TIPS) placement compared
to medical management for secondary prophylaxis for
esophageal variceal rebleeding. Official journal of the
American College of Gastroenterology 2017;112:S562.
Kwan SW, Allison SK, Gold LS, Shin DS. Cost-effectiveness
of transjugular intrahepatic portosystemic shunt versus largevolume
paracentesis in refractory ascites: results of a Markov
model incorporating individual patient-level meta-analysis
and nationally representative cost data. J Vasc Interv Radiol
;29:1705–12.
Article Metrics
Abstract View
: 272 times
Download : 201 times
DOI: 10.24871/2432023275
Refbacks
- There are currently no refbacks.
